The rhesus monkey (Macaca mulatta)manifests all features of human type 2 diabetes

Animal Models of Diabetes, Second Edition: Frontiers in Research

Volumn , Issue , 2007, Pages 251-270

  Hansen, Barbara C ^a   Tigno, Xenia T ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 47249135708     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (79)

1. ADA-Expert Committee. (2003) The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167.
2. American Diabetes Association. (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29:S43-S48.
3. Bernstein SL, Liu AM, Hansen BC, et al. (2000) Heat shock cognate-70 gene expression declines during normal aging of the primate retina. IOVS 41:2857-2862.
4. Bodkin NL. (1996) The rhesus monkey: providing insight into obesity and diabetes. Lab Anim 25:33-36.
5. Bodkin NL, Hannah JS, Ortmeyer HK, et al. (1990) Obesity and hyperlipidemia in the rhesus monkey: Interactions with the development of type 2 diabetes. In Lessons from Animal Diabetes, ed. Shafrir E, Renold AE. London: Smith-Gordon, 3:644-649.
6. Bodkin NL, Hannah JS, Ortmeyer HK, et al. (1993) Central obesity in rhesus monkeys: Association with hyperinsulinemia, insulin resistance and hypertriglyceridemia? Int J Obesity 17:53-61.
7. Bodkin NL, Hansen BC. (1995) Antihypertensive effects of captopril without adverse effects on glucose tolerance in hyperinsulinemic rhesus monkeys. J Med Primatol 24:1-6.
8. Bodkin NL, Metzger BL, Hansen BC. (1989) Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 256:E676-681.
9. Bodkin NL, Nicolson M, Ortmeyer HK, et al. (1996) Hyperleptinemia: Relationship to adiposity and insulin resistance in the spontaneously obese rhesus monkey. Horm Metab Res 28:674-678.
10. Bodkin NL, Sportsman R, DiMarchi RD, et al. (1991) Insulin-like growth factor-I in non-insulindependent diabetic monkeys: Basal plasma concentrations and metabolic effects of exogenously administered biosynthetic hormone. Metabolism 40:1131-1137.
11. Brady AG, Koritnik DR. (1985) The effects of ketamine anesthesia on glucose clearance in African green monkeys. J Med Primatol 14:99-107.
12. Charge SB, Esiri MM, Bethune CA, et al. (1996) Apolipoprotein E is associated with islet amyloid and other amyloidoses: Implications for Alzheimer’s disease. J Pathol 179:443-447.
13. Clark A, de Koning E, Hansen BC, et al. (1990) Islet amyloid in glucose intolerant and spontaneous diabetic Macaca mulatta monkeys. In Lessons from Animal Diabetes, ed. Shafrir E, Renold AE. London: Smith-Gordon, 3:502-506.
14. Clark A, de Koning EJ, Hattersley AT, et al. (1995) Pancreatic pathology in non-insulin dependent diabetes (NIDDM). Diabetes Res Clin Pract 28:S39-47.
15. Clark A, Jones LC, Koning E, et al. (2001) Decreased insulin secretion in type 2 diabetes: A problem of cellular mass or function? Diabetes 50 Suppl 1:S169-S171.
16. Clark A, Morris JF, Scott LA, et al. (1991) Intracellular formation of amyloid fibrils in betacells of human insulinoma and prediabetic monkey islets. In Amyloid and Amyloidosis, ed. Natvis JB. Amsterdam: Kluwer, 453-456.
17. Cornblath DR, Hillman MA, Striffler JS, et al. (1989) Peripheral neuropathy in diabetic monkeys. Diabetes 38:1365-1370.
18. Cusumano AM, Bodkin NL, Hansen BC, et al. (2002) Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. Am J Kidney Dis 40:1075-1085.
19. De Fronzo RA, Tobin JD, Andres R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223.
20. de Koning EJ, Charge S, Morris J, et al. (1995) Macrophages in pancreatic islet amyloidosis. In Amyloid and Amyloidosis, ed. Natvis JB. Amsterdam: Kluwer, 405-407.
21. de Koning EJ, van der Brand JJ, Mott VL, et al. (1998) Macrophages and pancreatic islet amyloidosis. Amyloid 1:247-245.
22. de Koning EJP, Hansen BC, Clark A. (1993) Diabetes mellitus in Macaca mulatta monkeys is characterized by severe islet amyloidosis and reduction in beta-cell population. Diabetologia 36:378-384.
23. Di Giacomo RF, Myers RE, Baez LR. (1971) Diabetes mellitus in a rhesus monkey (Macaca mulatta). Lab Anim Sci 21:572-574.
24. Ding SY, Tigno, XT, Hansen, BC. (2006) Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. Metabolism. In press.
25. Erwin JM, Tigno XT, Gerzanich G, et al. (2004) Age-related changes in fasting plasma cortisol in rhesus monkeys: Implications of individual differences for pathological consequences. J Gerontol A 59:424-432.
26. Green C. (1982) Pharmocology of drugs acting on the central nervous system. In Animal Aneasthesia, ed. Green C. London: Laboratory Animals Ltd., 29-43.
27. Hamilton CL, Ciaccia P. (1978) The course of development of glucose intolerance in the monkey (Macaca mulatta). J Med Primatol 7:165-173.
28. Hannah JS, Bodkin NL, Paidi MS, et al. (1995) Effects of Acipimox on the metabolism of free fatty acids and very low lipoprotein triglyceride. Acta Diabetol 32:279-283.
29. Hannah JS, Verdery RB, Bodkin NL, et al. (1991) Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 72:1067-1072.
30. Hansen BC. (1992) Obesity and diabetes in monkeys. In Obesity, ed. Brodoff PBaBN. New York: J.B. Lippincott Co., 256-265.
31. Hansen BC. (1996) Primate animal models in non-insulin dependent diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text, ed. LeRoith D, Olesfky JM. Philadelphia: Lippincott-Raven Publishers, 595-603.
32. Hansen BC. (2000) Primates in the experimental pharmacology of obesity. In Handbook of Experimental Pharmacology: Obesity, Pathology and Therapy, ed. Lockwood D, Heffner TG. Heidelberg: Springer-Verlag, 461-489.
33. Hansen BC. (2004a) Primate animal models of type 2 diabetes. In Diabetes Mellitus: A Fundamental and Clinical Text, ed. LeRoith D, Olefsky JM, Taylor S. Philadelphia: Lippincott Williams and Wilkins, 1059-1074.
34. Hansen BC. (2004b) Primates in the study of aging-associated obesity. In Handbook of Obesity, ed. Bray CB. New York: Marcel Dekker, Inc., 283-299.
35. Hansen BC, Bodkin NL. (1986) Heterogeneity of insulin responses: Phases leading to type 2 (noninsulin- dependent) diabetes mellitus in the rhesus monkey. Diabetologia 29:713-719.
36. Hansen BC, Bodkin NL. (1990) Beta-cell hyperresponsiveness: Earliest event in development of diabetes in monkeys. Am J Physiol 259:R612-617.
37. Hansen BC, Bodkin NL, Ortmeyer HK. (1999) Calorie restriction in nonhuman primates: Mechanisms of reduced morbidity and mortality. Toxicological Sci 52S:56-60.
38. Hansen BC, Jen KL, Schwartz J. (1988) Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obesity 12:433-443.
39. Hansen BC, Ortmeyer, HK, Bodkin NL. (1995) Obesity, Insulin-Resistance and Non-Insulin- Dependent Diabetes in Aging Monkeys: Implications for NIDDM in Humans. London: Smith-Gordon.
40. Hotta K, Funahashi T, Bodkin NL, et al. (2001) Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133.
41. Hotta K, Gustafson TA, Ortmeyer HK, et al. (1996) Regulation of obese (ob) mRNA and plasma leptin levels in rhesus monkeys: Effects of insulin, body weight and diabetes. J Biol Chem 271:25327-25331.
42. Hotta K, Gustafson TA, Ortmeyer HK, et al. (1998) Monkey leptin receptor mRNA: Sequence, tissue distribution, and mRNA expression in the adipose tissue of normal, hyperinsulinemic and type 2 diabetic rhesus monkeys. Obesity Res 6:353-360.
43. Hotta K, Gustafson TA, Yoshioka S, et al. (1998) Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinemia in rhesus monkeys. Int J Obesity 22:1000-1010.
44. Hotta K, Gustafson TA, Yoshioka S, et al. (1999) Age-related adipose tissue mRNA expression ADD1, PPARγ, lipoprotein lipase and GLUT4 glucose transporter in rhesus monkeys. J Gerontol: Biol Sci 54A:B183-B188.
45. Hotta K, Matsukawa M, Masahiko T, et al. (2001) Galectin-12, an adipose-expressed galectinlike molecule possessing an activity to induce apoptosis. J Biol Chem 276:34089-34097.
46. Howard C, Yasuda M. (1990) Diabetes mellitus in nonhuman primates: Recent research advances and current husbandry practices. J Med Primatol 19:609-625.
47. Howard JCF. (1983) Diabetes and carbohydrate impairment in nonhuman primates. In Nonhuman Primate Models for Human Diseases, ed. Dukelow EWR. Boca Raton, FL: CRC Press, 1-36.
48. Jen KL, Hansen BC, Metzger BL. (1985) Adiposity, anthropometric measures, and plasma insulin levels of rhesus monkeys. Int J Obesity 9:213-224.
49. Johnson MA, Lutty GA, McLeod DS, et al. (2005) Ocular structure and function in an aged monkey with spontaneous diabetes mellitus. Exp Eye Res 80:37-42.
50. Kemnitz J, Kraemer G. (1982) Assessment of glucoregulation in rhesus monkeys sedated with ketamine. Am J Med Primatol 3:201-210.
51. Kennington AS, Hill CR, Craig J, et al. (1990) Low urinary chiro-inositol excretion in noninsulin- dependent diabetes mellitus. N Engl J Med 323:373-378.
52. Kim SY, Johnson MA, McLeod DS, et al. (2004) Retinopathy in monkeys with spontaneous type 2 diabetes. Invest Ophthalmol Vis Sci 45:4543-4553.
53. Kim SY, Johnson MA, McLeod DS, et al. (2005) Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 54:1534-1542.
54. Kirk JH, Casey HW, Harwell JF, Jr. (1972) Diabetes mellitus in two rhesus monkeys. Lab Anim Sci 22:245-248.
55. Morton JL, Davenport M, Beloff-Chain A, et al. (1992) Correlation between plasma beta-cell tropin concentrations and body weight in obese rhesus monkeys. Am J Physiol 262:E963-967.
56. Naithani VK, Steffens GJ, Tager HS, et al. (1984) Isolation and amino-acid sequence determination of monkey insulin and proinsulin. Hoppe Seylers Z Physiol Chem 365:571-575.
57. National Institutes of Health Committee on Care and Use of Laboratory Animals. (1996) Guide to the Care and Use of Laboratory Animals. Washington, D.C.: U.S. Government Printing Office.
58. Oliver WR, Shenk JL, Snaith MR, et al. (2001) A selective peroxisome proliferator-activated receptor and agonist promotes reverse cholesterol transport. PNAS 98:5306-5311.
59. Ortmeyer HK. (1997) Insulin decreases skeletal muscle cAMP-dependent protein kinase (PKA) activity in normal monkeys and increases PKA activity in insulin-resistant rhesus monkeys. J Basic Clin Physiol Pharmacol 8:223-235.
60. Ortmeyer HK, Adall Y, Marciani KR, et al. (2005) Skeletal muscle glycogen synthase subcellular localization: Effects of insulin and PPAR-alpha agonist (K-111) administration in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288:R1509-1517.
61. Ortmeyer HK, Bodkin NL. (1998) Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys. Am J Physiol 274:G1005-1010.
62. Ortmeyer HK, Bodkin NL, Hansen BC. (1993a) Adipose tissue glycogen synthase activation by in vivo insulin in spontaneously insulin-resistant and type 2 (non-insulin-dependent) diabetic rhesus monkeys. Diabetologia 36:200-206.
63. Ortmeyer HK, Bodkin NL, Hansen BC. (1993b) Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Am J Physiol 265:R552-558.
64. Ortmeyer HK, Bodkin NL, Hansen BC. (1997) Insulin regulates liver glycogen synthase and glycogen phosphorylase activity reciprocally in rhesus monkeys. Am J Physiol 272:E133-138.
65. Ortmeyer HK, Bodkin NL, Haney J, et al. (2000) A thiazolidinedione improves in vivo insulin action on skeletal muscle glycogen synthase in insulin-resistant monkeys. Int J Exp Diabetes Res 1:195-202.
66. Ortmeyer HK, Bodkin NL, Hansen, BC, et al. (1995) In vivo D-chiroinositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in rhesus monkeys. J Nutr Biochem 6:499-503.
67. Ortmeyer HK, Bodkin NL, Lilley K, et al. (1993) Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology 132:640-645.
68. Ortmeyer HK, Bodkin, NL, Yoshioka S, et al. (1999) A thiazolidinedione improves insulin action on skeletal muscle glycogen synthase in insulin resistant rhesus monkeys. Diabetes 48:A231.
69. Ortmeyer HK, Huang LC, Zhang L, et al. (1993) Chiroinositol deficiency and insulin resistance. II. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys. Endocrinology 132:646-651.
70. Ortmeyer HK, Larner J, Hansen BC. (1995) Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. Obesity Res 3 (Suppl 4):605S-608S.
71. Otsuji T, McLeod DS, Hansen BC, et al. (2002) Immunohistochemical staining and morphometric analysis of the monkey choroidal vasculature. Exp Eye Res 75:201-208.
72. Robison W, Laver N. (1991) Diabetic retinal microangiopathies in humans and animal models: Similar histological progression. Inv Ophthal Vis Sci 32:915.
73. Schafer SA, Hansen BC, Volkl A, et al. (2004) Biochemical and morphological effects of K- 111, a peroxisome proliferator-activated receptor (PPAR) alpha activator, in nonhuman primates. Biochem Pharmacol 68:239-251.
74. Schwartz SM, Kemnitz JW, Howard CF, Jr. (1993) Obesity in free-ranging rhesus macaques. Int J Obesity Related Metab Disorders 17:1-9.
75. Tigno XT, Ding SY, Hansen BC. (2006) Paradoxical increase in dermal microvascular flow in prediabetes associated with elevated levels of CRP. Clin Hemorheol Microcirc 34:273-282.
76. Tigno XT, Gerzanich G, Hansen BC. (2004) Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 59:1081-1088.
77. Uno H, Kemnitz J, Warner J, et al. (1985) Spontaneous diabetes mellitus in aged captive rhesus monkeys. Lab Invest 52:572-574.
78. Winegar DA, Brown PJ, Wilkison WO, et al. (2001) Effects of fenofibrate on lipid parameters in obese rhesus monkeys. J Lipid Res 42:1543-1551.
79. Young AA, Gedulin BR, Bhavsar S, et al. (1999) Glucose-lowering and insulin-sensitizing actions of exendin-4: Studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats and diabetic monkeys (Macaca mulatta). Diabetes 48:1026-103.